Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.63 |
| ▸ | RAB9A | P51151 | 8/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | IGF2BP2 | Q9Y6M1 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 6/20 | 0.59 |
| ▸ | HPGD | P15428 | 5/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11593721 | 0.81 | IGF2BP2 (0.81) | NPC1RAB9ASMN1; SMN2ALDH1A1IGF2BP2 | |
| SCHEMBL11339738 | 0.80 | NPC1 (0.74) | NPC1RAB9ASMN1; SMN2ALDH1A1IGF2BP2 | |
| SCHEMBL563078 | 0.78 | NPC1 (1.00) | NPC1RAB9ASMN1; SMN2ALDH1A1IGF2BP2 | |
| SCHEMBL28710441 | 0.75 | NPC1 (0.74) | NPC1RAB9ASMN1; SMN2ALDH1A1IGF2BP2 | |
| SCHEMBL29575333 | 0.75 | NPC1 (0.78) | NPC1RAB9ASMN1; SMN2ALDH1A1IGF2BP2 | |
| SCHEMBL285733 | 0.75 | NPC1 (0.78) | NPC1RAB9ASMN1; SMN2ALDH1A1IGF2BP2 | |
| SCHEMBL11691319 | 0.74 | NPC1 (0.58) | NPC1RAB9ASMN1; SMN2ALDH1A1IGF2BP2 | |
| SCHEMBL11593974 | 0.74 | NPC1 (0.72) | NPC1RAB9ASMN1; SMN2ALDH1A1IGF2BP2 | |
| SCHEMBL11396153 | 0.74 | NPC1 (0.72) | NPC1RAB9ASMN1; SMN2ALDH1A1IGF2BP2 | |
| SCHEMBL7086957 | 0.73 | NPC1 (0.70) | NPC1RAB9ASMN1; SMN2ALDH1A1IGF2BP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7507750-B2 | Stabilized ascorbic acid derivative | SHOWA DENKO K.K. (JP) | 2009-03-24 | — | — | US | disclosed |
| US-20070141000-A1 | STABILIZED ASCORBIC ACID DERIVATIVE | SHOWA DENKO K.K. | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070141000-A1 | STABILIZED ASCORBIC ACID DERIVATIVE | SOD1, PROC, RBP1 | NPC1 727/4885RAB9A 453/4885SMN1; SMN2 630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.